[1] LUI VC, HUI KP, BABU RO, et al. Human liver organoid derived intra-hepatic bile duct cells support SARS-CoV-2 infection and replication. Sci Rep. 2022;12(1):5375.
[2] HUCH M, GEHART H, VAN BOXTEL R, et al. Long-term culture of genome-stable bipotent stem cells from adult human liver. Cell. 2015; 160(1-2):299-312.
[3] AKBARI S, SEVINÇ GG, ERSOY N, et al. Robust, Long-Term Culture of Endoderm-Derived Hepatic Organoids for Disease Modeling. Stem Cell Rep. 2019;13(4):627-641.
[4] 林丽,雷妙,林佳漫,等.肝脏类器官的研究进展及应用[J].中国科学:生命科学,2023,53(2):185-195.
[5] ASRANI SK, DEVARBHAVI H, EATON J, et al. Burden of liver diseases in the world. J Hepatol. 2019;70(1):151-171.
[6] KIM J, KOO BK, KNOBLICH JA. Human organoids: model systems for human biology and medicine. Nat Rev Mol Cell Biol. 2020;21(10):571-584.
[7] 任全娥.大数据背景下的文献计量学研究进展与学科融合[J].情报理论与实践,2019,42(1):48-52.
[8] 潘颖,孙瑜峥,刘岩.科技文献阅读中语素意识研究的可视化分析[J].情报科学,2019,37(12):123-127.
[9] 史艳龙,方德宝,冉启豪,等.基于Web of Science数据库的2000-2019年结直肠癌肝转移文献计量分析[J].中国普通外科杂志, 2020,29(4):400-411.
[10] 谭令,龙霖梓,邓秘,等.抗血小板活化的文献计量学及可视化分析[J].世界科学技术-中医药现代化,2022,24(1):195-208.
[11] 陈莹,常静玲,李新龙,等.基于CiteSpace的近20年蚓激酶相关研究的文献计量学分析[J].世界科学技术-中医药现代化,2022, 24(1):388-397.
[12] BROUTIER L, MASTROGIOVANNI G, VERSTEGEN MM, et al. Human primary liver cancer-derived organoid cultures for disease modeling and drug screening. Nat Med. 2017;23(12):1424-1435.
[13] TAKEBE T, SEKINE K, ENOMURA M, et al. Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature. 2013; 499(7459):481-484.
[14] BOJ SF, HWANG CI, BAKER LA, et al. Organoid models of human and mouse ductal pancreatic cancer. Cell. 2015;160(1-2):324-338.
[15] CLEVERS H. Modeling Development and Disease with Organoids. Cell. 2016; 165(7):1586-1597.
[16] 高振,徐一喆,董竞成.基于文献计量学的中外中医药研究主题及热点比较[J].中医杂志,2022,63(13):1283-1290.
[17] SATO T, VRIES RG, SNIPPERT HJ, et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature. 2009;459(7244): 262-265.
[18] HUCH M, DORRELL C, BOJ SF, et al. In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration. Nature. 2013; 494(7436): 247-250.
[19] 王溢贤,朱妍静,王红阳,等.肝脏类器官研究进展与应用[J].中国细胞生物学学报,2021,43(6):1132-1141.
[20] CORRÒ C, NOVELLASDEMUNT L, LI VSW. A brief history of organoids. Am J Physiol Cell Physiol. 2020;319(1):C151-C165.
[21] AKBARI S, ARSLAN N, SENTURK S, et al. Next Generation Liver Medicine Using Organoid Models. Front Cell Dev Biol. 2019;7:345.
[22] 赵梦雨,代荣阳,张钰哲.从免疫浸润角度分析肝癌患者性别和预后生存关系的差异[J].昆明理工大学学报(自然科学版),2020, 45(6):119-127.
[23] PRIOR N, INACIO P, HUCH M. Liver organoids: from basic research to therapeutic applications. Gut. 2019;68(12):2228-2237.
[24] 丁明宁,薛晓勇,李晓骄阳.肝胆类器官在中药研究中的应用进展[J].中草药,2021,52(18):5789-5795.
[25] ZHAO Y, YIN X, QIN H, et al. Two supporting factors greatly improve the efficiency of human iPSC generation. Cell Stem Cell. 2008;3(5):475-479.
[26] LIN Y, FANG ZP, LIU HJ, et al. HGF/R-spondin1 rescues liver dysfunction through the induction of Lgr5+ liver stem cells. Nat Commun. 2017; 8(1):1175.
[27] DEKKERS JF, WIEGERINCK CL, DE JONGE HR, et al. A functional CFTR assay using primary cystic fibrosis intestinal organoids. Nat Med. 2013; 19(7):939-945.
[28] 王佳慧,郭新华,郑博文,等.基于miR-125b/NLRP3信号通路探讨莪术醇抗肝纤维化的作用机制[J]. 中华中医药学刊,2022,40(11): 95-99.
[29] 王挺帅,张荣臻,王明刚,等.基于Kuffer细胞NF-κB信号通路探讨解毒化瘀颗粒拮抗肝功能衰竭的作用机制[J].中华中医药杂志, 2021,36(4):1878-1883.
[30] BAI Y, YANG Z, XU X, et al. Direct chemical induction of hepatocyte-like cells with capacity for liver repopulation. Hepatology. 2023;77(5): 1550-1565.
|